TURQUOISE regimen active against HCV-HIV coinfection
WASHINGTON – Early studies show that a new, combined antiviral regimen seems to suppress hepatitis C viremia while keeping HIV viremia stable in coinfected patients. Dr. Joseph Eron presented phase...
